Vision-Sciences to Host Third Quarter Fiscal 2014 Results Call
24 janv. 2014 09h44 HE
|
Vision-Sciences, Inc.
ORANGEBURG, N.Y., Jan. 24, 2014 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable...
Vision-Sciences' EndoSheath(R) Technology Offers Patented Solution to "Nightmare Bacteria"
13 janv. 2014 08h00 HE
|
Vision-Sciences, Inc.
ORANGEBURG, N.Y., Jan. 13, 2014 (GLOBE NEWSWIRE) -- An outbreak of "Nightmare Bacteria," also known as the "Super Bug," has raised new alarm bells in the healthcare industry over patient safety. The...
Vision-Sciences Selected as Preferred Vendor for Endoscopy Equipment by 21st Century Oncology
19 déc. 2013 08h00 HE
|
Vision-Sciences, Inc.
Orangeburg, NY, Dec. 19, 2013 (GLOBE NEWSWIRE) -- Orangeburg, NY - December 19, 2013-
Vision-Sciences, Inc. (NASDAQ: VSCI), a leading provider of unique
flexible endoscopic products utilizing its...
Vision-Sciences Launches Authorized Repair Center for Europe
06 déc. 2013 08h00 HE
|
Vision-Sciences, Inc.
ORANGEBURG, N.Y., Dec. 6, 2013 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable...
Vision-Sciences Promotes Howard Zauberman to Chief Executive Officer and President, and Appoints Him to Board of Directors
26 nov. 2013 08h00 HE
|
Vision-Sciences, Inc.
ORANGEBURG, N.Y., Nov. 26, 2013 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable...
Annual ECRI List of Top 10 Health Technology Hazards Underscores Critical Need for Vision-Sciences' EndoSheath(R) Technology
18 nov. 2013 08h00 HE
|
Vision-Sciences, Inc.
ORANGEBURG, N.Y., Nov. 18, 2013 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable...
Vision-Sciences to Host One-on-Ones at Brean Capital 2013 Life Sciences Summit in NYC on November 25th
15 nov. 2013 13h00 HE
|
Vision-Sciences, Inc.
ORANGEBURG, N.Y., Nov. 15, 2013 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI) announced today that Howard Zauberman, Interim Chief Executive Officer and Keith Darragh, VP Finance, will host...
Vision-Sciences Announces Revenue of $4.0 Million for Second Quarter and $7.6 Million for First Half of Fiscal 2014
11 nov. 2013 16h30 HE
|
Vision-Sciences, Inc.
ORANGEBURG, N.Y., Nov. 11, 2013 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable...
New Peer-Reviewed Publication Demonstrates Patient Safety Aspects of Vision-Sciences' EndoSheath(R) Technology for Flexible Cystoscopes
06 nov. 2013 08h00 HE
|
Vision-Sciences, Inc.
ORANGEBURG, N.Y., Nov. 6, 2013 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI) announced today the publication of positive outcomes of a clinical study that evaluated the durability and...
Vision-Sciences to Host Second Quarter Fiscal 2014 Results Call
28 oct. 2013 16h30 HE
|
Vision-Sciences, Inc.
ORANGEBURG, N.Y., Oct. 28, 2013 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable...